MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Maturities of investments$311,900K Proceeds from ft836 cirmaward-$4,000K Proceeds from ft819 cirmaward$1,490K Proceeds from sale ofproperty and equipment$362K Net cash provided byinvesting activities$111,166K Net cash provided byfinancing activities$5,490K Canceled cashflow$201,096K Net change in cash,cash equivalents and...$10,572K Canceled cashflow$106,084K Purchases of investments$195,143K Purchases of property andequipment$5,953K Stock-based compensation$24,924K Depreciation andamortization$12,901K Prepaid expenses andother assets-$5,179K Accounts receivable-$2,624K Loss on disposal ofproperty and equipment-$9K Interest income$11,052K Change in fair value ofstock price...-$244K Other income$93K Net cash used inoperating activities-$106,084K Canceled cashflow$45,637K Total other income$11,389K Net loss-$136,315K Canceled cashflow$11,389K Accounts payable andaccrued expenses-$9,027K Accretion andamortization of premiums and...$3,606K Right-of-use assets and leaseliabilities, net-$2,517K Changes in fair value ofstock price...-$244K Deferred revenue-$12K Collaboration revenue$6,646K Loss from operations-$147,704K Canceled cashflow$6,646K Total operatingexpenses$154,350K
Cash Flow
source: myfinsight.com

FATE THERAPEUTICS INC (FATE)

FATE THERAPEUTICS INC (FATE)